Intensity-modulated radiotherapy in the treatment of breast cancer.

[1]  J. Yarnold,et al.  Intensity-modulated Radiotherapy for the Treatment of Breast Cancer. , 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

[2]  C. Coles,et al.  Randomized controlled trial of forward-planned intensity modulated radiotherapy for early breast cancer: interim results at 2 years. , 2012, International journal of radiation oncology, biology, physics.

[3]  Radhe Mohan,et al.  Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy. , 2010, International journal of radiation oncology, biology, physics.

[4]  Lei Xing,et al.  American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guidelines for image-guided radiation therapy (IGRT). , 2010, International journal of radiation oncology, biology, physics.

[5]  C. Fiorino,et al.  IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  G. Viani,et al.  Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials. , 2009, International journal of radiation oncology, biology, physics.

[7]  Yan Chen,et al.  Breast intensity-modulated radiation therapy reduces time spent with acute dermatitis for women of all breast sizes during radiation. , 2009, International journal of radiation oncology, biology, physics.

[8]  F. Kjaer-Kristoffersen,et al.  Pulmonary toxicity following IMRT after extrapleural pneumonectomy for malignant pleural mesothelioma. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  B. Yaremko,et al.  Systematic review of dose-volume parameters in the prediction of esophagitis in thoracic radiotherapy. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  K Leszczynski,et al.  Organisational standards for the delivery of intensity-modulated radiation therapy in Ontario. , 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).

[11]  B. Maciejewski,et al.  Does incidental irradiation with doses below 50 gy effectively reduce isolated nodal failures in non-small-cell lung cancer: dose-response relationship. , 2009, International journal of radiation oncology, biology, physics.

[12]  J. Lebesque,et al.  Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer. , 2009, International journal of radiation oncology, biology, physics.

[13]  R. Pötter,et al.  Moderate risk-adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74 Gy , 2009, Strahlentherapie und Onkologie.

[14]  A. De Gaetano,et al.  Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  Per Hall,et al.  Cardiac doses from Swedish breast cancer radiotherapy since the 1950s. , 2009, Radiotherapy and Oncology.

[16]  P. Johnstone,et al.  Long-term outcomes of IMRT for breast cancer: a single-institution cohort analysis. , 2008, International journal of radiation oncology, biology, physics.

[17]  F. Fazio,et al.  Reduction of Acute Toxicity with IMRT and Tomotherapy in the Treatment of Pelvic Nodes during Post-operative Radiotherapy for High and Intermediate Risk Prostate Patients , 2008 .

[18]  Charles S Mayo,et al.  Hybrid IMRT for treatment of cancers of the lung and esophagus. , 2008, International journal of radiation oncology, biology, physics.

[19]  Yoshiya Yamada,et al.  Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes. , 2008, International journal of radiation oncology, biology, physics.

[20]  Wayne Beckham,et al.  A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Andrew Jackson,et al.  Intensity-modulated radiation therapy (IMRT) for inoperable non-small cell lung cancer: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  Y. Yamada,et al.  Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. , 2008, International journal of radiation oncology, biology, physics.

[23]  K. Bujko,et al.  Incidental irradiation of mediastinal and hilar lymph node stations during 3D-conformal radiotherapy for non-small cell lung cancer , 2008, Acta oncologica.

[24]  Lei Dong,et al.  Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. , 2008, International journal of radiation oncology, biology, physics.

[25]  E. Yorke,et al.  Involved-field radiation therapy for inoperable non small-cell lung cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  J. Battermann,et al.  Health-related quality of life in patients with locally advanced prostate cancer after 76 Gy intensity-modulated radiotherapy vs. 70 Gy conformal radiotherapy in a prospective and longitudinal study. , 2007, International journal of radiation oncology, biology, physics.

[27]  Tianyu Li,et al.  Breast IMRT Reduces Time Spent with Acute Dermatitis For Women of All Breast Sizes During Radiation , 2007 .

[28]  S. Leung,et al.  Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  H. Nishiyama,et al.  Health-related quality-of-life after external beam radiation therapy for localized prostate cancer: intensity-modulated radiation therapy versus conformal radiation therapy , 2007, Prostate Cancer and Prostatic Diseases.

[30]  S. Jolly,et al.  Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. , 2007, International journal of radiation oncology, biology, physics.

[31]  G. Ezzell,et al.  Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer. , 2007, International journal of radiation oncology, biology, physics.

[32]  G. Rodrigues,et al.  In regard to Allen et al.: Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma (Int J Radiat Oncol Biol Phys 2006;65:640-645). , 2007, International journal of radiation oncology, biology, physics.

[33]  M. Parmar,et al.  Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. , 2007, The Lancet. Oncology.

[34]  Jinming Yu,et al.  A Randomized Study of Involved-Field Irradiation Versus Elective Nodal Irradiation in Combination With Concurrent Chemotherapy for Inoperable Stage III Nonsmall Cell Lung Cancer , 2007, American journal of clinical oncology.

[35]  Radhe Mohan,et al.  Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. , 2007, International journal of radiation oncology, biology, physics.

[36]  Comparison of inverse-planned three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for non-small-cell lung cancer. , 2007, International journal of radiation oncology, biology, physics.

[37]  Richard Symonds-Tayler,et al.  Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[38]  Patrick A. Kupelian,et al.  Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience. , 2007, International journal of radiation oncology, biology, physics.

[39]  E. Horwitz,et al.  2209: Intensity Modulated Radiation Therapy for Prostate Cancer: Preliminary Results on Treatment Morbidity Compared to 3-D Conformal Radiation Therapy , 2006 .

[40]  Lech Papiez,et al.  Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  J. Lebesque,et al.  Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. , 2006, International journal of radiation oncology, biology, physics.

[42]  Patrice Jalade,et al.  Potential benefits of using non coplanar field and intensity modulated radiation therapy to preserve the heart in irradiation of lung tumors in the middle and lower lobes. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[43]  G. Sanguineti,et al.  Does Treatment of the Pelvic Nodes with IMRT Increase Late Rectal Toxicity over Conformal Prostate-Only Radiotherapy to 76 Gy? , 2006, Strahlentherapie und Onkologie.

[44]  Laurence Court,et al.  Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. , 2006, International journal of radiation oncology, biology, physics.

[45]  J. Deasy,et al.  Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters. , 2006, International journal of radiation oncology, biology, physics.

[46]  C. Ma,et al.  Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial. , 2006, International journal of radiation oncology, biology, physics.

[47]  Marcel van Herk,et al.  Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis. , 2006, International Journal of Radiation Oncology, Biology, Physics.

[48]  A. Hanlon,et al.  Intensity Modulated Radiation Therapy (IMRT) Decreases Acute Skin Toxicity for Women Receiving Radiation for Breast Cancer , 2006, American journal of clinical oncology.

[49]  R. Collins,et al.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[50]  Patrick A Kupelian,et al.  Hypofractionated intensity-modulated radiotherapy (70 gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes. , 2005, International journal of radiation oncology, biology, physics.

[51]  R. T. Ten Haken,et al.  High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study. , 2005, International journal of radiation oncology, biology, physics.

[52]  Daniel W. Miller,et al.  Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. , 2005, JAMA.

[53]  Rakesh R. Patel,et al.  Potential for radiation therapy technology innovations to permit dose escalation for non-small-cell lung cancer. , 2005, Clinical lung cancer.

[54]  Jeff M Michalski,et al.  Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V. , 2005, International journal of radiation oncology, biology, physics.

[55]  S. Thibodeau,et al.  Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003. , 2005, Chest.

[56]  Joos V Lebesque,et al.  Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer. , 2005, International journal of radiation oncology, biology, physics.

[57]  C. Ling,et al.  Results of a phase I dose‐escalation study using three‐dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma , 2005, Cancer.

[58]  James S Goodwin,et al.  Risk of cardiac death after adjuvant radiotherapy for breast cancer. , 2005, Journal of the National Cancer Institute.

[59]  P. Koper,et al.  Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. , 2005, International journal of radiation oncology, biology, physics.

[60]  Jeffrey Bradley,et al.  Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. , 2005, International journal of radiation oncology, biology, physics.

[61]  R. Eeles,et al.  Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects , 2005, British Journal of Cancer.

[62]  M. Socinski,et al.  Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: a dose-escalation phase I trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[63]  T. Araki,et al.  Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinoma , 2004, Cancer.

[64]  Michael Lock,et al.  Prediction of radiation pneumonitis by dose - volume histogram parameters in lung cancer--a systematic review. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[65]  Radhe Mohan,et al.  Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. , 2004, International journal of radiation oncology, biology, physics.

[66]  Thomas Guerrero,et al.  Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer. , 2004, International journal of radiation oncology, biology, physics.

[67]  Richard K Valicenti,et al.  Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV. , 2004, International journal of radiation oncology, biology, physics.

[68]  Roberto Andorno,et al.  The Precautionary Principle: A New Legal Standard for a Technological Age , 2004 .

[69]  Kai-Liang Wu,et al.  Three-dimensional conformal radiation therapy for non-small-cell lung cancer: a phase I/II dose escalation clinical trial. , 2003, International journal of radiation oncology, biology, physics.

[70]  Di Yan,et al.  Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. , 2003, International journal of radiation oncology, biology, physics.

[71]  B. Murray,et al.  An evaluation of forward and inverse radiotherapy planning using Helax-TMS (version 6.0) for lung cancer patients treated with RTOG 93-11 dose-escalation protocol. , 2003, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[72]  A. Markoe,et al.  Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II. , 2003, International journal of radiation oncology, biology, physics.

[73]  A. Markoe,et al.  Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy). , 2002, International journal of radiation oncology, biology, physics.

[74]  S. Marnitz,et al.  Intraindividual Comparison of Conventional Three-Dimensional Radiotherapy and Intensity Modulated Radiotherapy in the Therapy of Locally Advanced Non-Small Cell Lung Cancer , 2002, Strahlentherapie und Onkologie (Print).

[75]  C. Reddy,et al.  Dose/Volume Relationship of Late Rectal Bleeding After External Beam Radiotherapy for Localized Prostate Cancer: Absolute or Relative Rectal Volume? , 2001, Cancer journal.

[76]  A. Markoe,et al.  Trade-off to low-grade toxicity with conformal radiation therapy for prostate cancer on Radiation Therapy Oncology Group 9406. , 2002, Seminars in radiation oncology.

[77]  S G Baker,et al.  Rethinking historical controls. , 2001, Biostatistics.

[78]  C C Ling,et al.  Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[79]  T. Whelan,et al.  Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[80]  J A Purdy,et al.  Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) , 1999, International journal of radiation oncology, biology, physics.

[81]  A Harvey,et al.  Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[82]  D. Dearnaley,et al.  Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial , 1999, The Lancet.

[83]  K. Zedeler,et al.  Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy , 1997 .

[84]  N. Le,et al.  Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. , 1997, The New England journal of medicine.

[85]  Mike Clarke,et al.  EFFECTS OF RADIOTHERAPY AND SURGERY IN EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS , 1995 .

[86]  Anthony Howell,et al.  Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. , 1995, The New England journal of medicine.

[87]  A Gafni,et al.  The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.